Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
23,771,791
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
714,327
-
Shares change
-
+203,981
-
Total reported value, excl. options
-
$1,207,232
-
Value change
-
+$328,214
-
Put/Call ratio
-
1.8%
-
Number of buys
-
7
-
Number of sells
-
6
-
Price
-
$1.69
Institutional Holders of NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP) as of Q3 2024
As of 30 Sep 2024 NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP) had 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 714,327 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Anson Funds Management LP, AdvisorShares Investments LLC, GEODE CAPITAL MANAGEMENT, LLC, SABBY MANAGEMENT, LLC, BlackRock, Inc., STATE STREET CORP, One Wealth Management Investment & Advisory Services, LLC, TOWNSQUARE CAPITAL LLC, and MORGAN STANLEY.
This table shows 24 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.